Evento

Interaction of T4 and E2 on mammary carcinogenesis (ex vivo and in vitro)

Cano, Rocio Yasmin Icon; Gomez, Silvina Esther Icon; Ferrando, Matías Icon; Zyla, Leila Ester Icon; Pistone Creydt, Virginia Icon; Caron, Ruben Walter Icon; López Fontana, Constanza Matilde Icon

Otros responsables

Fecha

2024

Editorial

Fundación Revista Medicina

Revista

Título del libro

Nombre del evento

Reunión Conjunta SAIC SAFIS ALACF 2024; LXIX Reunión Anual de la Sociedad Argentina de Investigación Clínica; XXVI Sociedad Argentina de Fisiología y Asociación Latinoamericana de Ciencias Fisiológicas

Fecha del evento

2024-11-19

Institución organizadora

Sociedad Argentina de Investigación Clínica
Sociedad Argentina de Fisiología
Asociación Latinoamericana de Ciencias Fisiológicas

ISSN

1669-9106

eISSN

ISBN

Idioma

Inglés

Tipo del evento

Reunión

Clasificación temática

Resumen

Hypothyroidism seems to be a protective factor against breast cancer (BCa) though long-term exposure or high doses of thyroxine (T4) may increase BCa risk. Our previous studies indicated that hypothyroidism prolonged the latency, reduced the incidence, and retarded the growth of tumors in rats, and that T4 may influence mammary carcinogenesis by interacting with other hormone pathways. In this study, our aim was to investigate the biological impact of T4 alone or combined with estradiol (E2) on mammary tumors of hypo- and euthyroid rats, as well as human BCa cell lines. Female Sprague-Dawley rats were treated with a single dose of dimethylbenzathracene and were divided into two groups: hypothyroidism (HypoT; 0.01% 6-N-propyl-2-thiouracil -PTU- in drinking water, n = 20) and EUT (untreated control, n = 20). At sacrifice, tumor explants were obtained and treated either with 10-9 M T4, E2, or a combination, or DMEM/ F12 only as control for 15 min to evaluate intracellular signaling pathways, and after 24 h to evaluate changes in the expression of proteins related to apoptosis and proliferation by immunohistochemistry and Western Blot. In vitro, MCF-7 cells were treated with the same treatments. We assessed cell proliferation via MTT assays, and cell viability using Trypan Blue and the expression of proteins related to proliferation and apoptosis by immunocytochemistry and Western Blot. In HypoT tumor, T4+E2 stimulated proliferation, as evidenced by increased expression of Ki67 and mitotic/apoptotic index. In addition, suppressed apoptotic processes, as indicated by reduced expression of caspases 3 and PARP. In vitro, T4 induced MCF7 cell proliferation (p=0.012), viability (p=0.025) after 24h treatment. T4+E2 also enhanced the proliferation (p= 0.013) and viability of MCF-7 after 48 h, and activated the pERK/ERK pathway similarly to T4 alone (p < 0.05). In conclusion, T4 tends to enhance the action of E2 in proliferation and the effect of their interaction depends on the thyroid status.

Colecciones

Aprobación

Revisión

Complementado por

Referenciado por

Licencia Creative Commons

Excepto donde se indique lo contrario, la licencia de este ítem se describe como by-nc-sa